Health & Fitness / The Economic Times
A relook at the survey data was necessitated by instances of repeated measles outbreaks after the COVID-19 pandemic, the report by (by Rema Nagarajan) said.
Serum Institute of India halted Covishield vaccine manufacturing and supply in December 2021 amid side effects concerns and Astrazeneca's withdrawal of Vaxzervria.
India's MedTech industry is poised for an exponential growth, set to reach USD 50 bn by 2030 from the current USD 14 billion.
Delius Pharma registered a 35 percent rise in sales in FY23 to 24, with plans to set up multiple manufacturing units in India for finished formulation and API production.
Max Healthcare Institute Ltd plans to invest Rs 2,500 crore in Uttar Pradesh (UP) which includes setting up of a new 500 beds hospital on 5.6-acre parcel of land located at Shaheed Path and augmentation of capacity of the acquired facility.